Moreover, the knockdown of LINC00673 enhanced bax expression and reduced bcl-2 and cyclin D1 levels in breast cancer cells, confirming that LINC00673 is involved in apoptosis and cell cycle progression (Fig. 2h). Here, BCL2 is linked to breast carcinoma.